Comparison of S-nitrosoglutathione- and staurosporine-induced apoptosis in human neural cells

Download
  1. (PDF, 2 MB)
  2. Get@NRC: Comparison of S-nitrosoglutathione- and staurosporine-induced apoptosis in human neural cells (Opens in a new window)
DOIResolve DOI: http://doi.org/10.1139/cjpp-2014-0053
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleCanadian Journal of Physiology and Pharmacology
ISSN0008-4212
1205-7541
Volume92
Issue12
Pages10011011; # of pages: 11
Subjectneural progenitors; caspase 3; caspase 8; BAX; BCL-XL; mitochondria; NT2; hNP1; SH-SY5Y
AbstractS-nitrosoglutathione (GSNO) is an endogenously produced S-nitrosylating compound that controls the function of various proteins. While a number of rodent cell lines have been used to study GSNO-induced apoptosis, the mechanisms of action remain to be evaluated in human cells and in parallel with other common apoptosis-inducing agents. In this study, we compared the pro-apoptotic effects of GSNO and staurosporine (STS) on human neural progenitors (NT2, hNP1) and neuroblasts (SH-SY5Y). We show that these cells exhibit comparable levels of susceptibility to GSNO- and STS-induced apoptotic cell death, as demonstrated by condensed nuclei and CASP3 activation. Mechanistic differences in apoptotic responses were observed as differential patterns of DNA fragmentation and levels of BAX, BCL-XL, CASP8, and p-ERK in response to GSNO and STS treatment. Mitochondrial membrane potential analysis revealed that NT2 and hNP1 cells, but not SH-SY5Y cells, undergo mitochondrial hyperpolarization in response to short-term exposure to STS prior to undergoing subsequent depolarization. This is the first study to report differences in apoptotic responses to GSNO and STS in 3 complementary human neural cell lines. Furthermore, these cells represent useful tools in cell pharmacological paradigms in which susceptibility to apoptosis-inducing agents needs to be assessed at different stages of neural cell fate commitment and differentiation.
Publication date
PublisherCanadian Science Publishing
LanguageEnglish
AffiliationHuman Health Therapeutics; National Research Council Canada
Peer reviewedYes
NRC numberNRC-HHT-53227
NPARC number21275330
Export citationExport as RIS
Report a correctionReport a correction
Record identifier0f2701f3-27d7-43df-ad66-fc1bea5f7215
Record created2015-06-10
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)